2004D-0035 - Draft Guidance for Industry on the Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis; Availability
FDA Comment Number : EC3
Submitter : Ms. Kathryn Penhale Date & Time: 04/13/2004 12:04:11
Organization : Wyeth Pharmaceuticals Inc
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See attached.